Alterity Therapeutics ($ATHE) Insider Trading & Smart Money Activity

Alterity Therapeutics Limited · Biotechnology · Latest filing Jun 30, 2026

Alterity Therapeutics Limited ($ATHE) has 3 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

3

ATHE insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ATHE insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 30, 2026	Analyst	Jones Trading	Reiterates to buy		PT $16		+2.2%	-16.2%			Read
Jun 16, 2026	Analyst	Ladenburg Thalmann	Raises to buy		PT $10		+6.7%	+9.5%			Read
Jun 16, 2026	Analyst	Ladenburg Thalmann	Raises to buy		PT $10		+6.7%	+9.5%			Read

1W / 1M / 6M = how ATHE moved from the trade or filing date.

Analyst ratings on ATHE

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 30, 2026	Jones Trading	Reiterates	buy	$16	+2.2%	-16.2%		Read
Jun 16, 2026	Ladenburg Thalmann	Raises	buy	$10	+6.7%	+9.5%		Read
Jun 16, 2026	Ladenburg Thalmann	Raises	buy	$10	+6.7%	+9.5%		Read

Other biotechnology stocks

• $PLRX
• $GOSS
• $APLM
• $TENX
• $SPRO
• $BOLD
• $HYPD
• $XLO

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.